These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36313688)

  • 1. Atypical metanephric adenoma: Shares similar histopathological features and molecular changes of metanephric adenoma and epithelial-predominant Wilms' tumor.
    Yin X; Zhang X; Pan X; Tan J; Zheng L; Zhou Q; Chen N
    Front Oncol; 2022; 12():1020456. PubMed ID: 36313688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metanephric Adenoma-Epithelial Wilms Tumor Overlap Lesions: An Analysis of BRAF Status.
    Wobker SE; Matoso A; Pratilas CA; Mangray S; Zheng G; Lin MT; Debeljak M; Epstein JI; Argani P
    Am J Surg Pathol; 2019 Sep; 43(9):1157-1169. PubMed ID: 31192863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinicopathological features of adult Wilms tumor with BRAF V600E mutation].
    Gan HL; Wang QF; Zhu XL; Lyu H; Wang J
    Zhonghua Bing Li Xue Za Zhi; 2023 Dec; 52(12):1210-1215. PubMed ID: 38058036
    [No Abstract]   [Full Text] [Related]  

  • 4. [Molecular features of metanephric adenoma and their values in differential diagnosis].
    Wang X; Shi SS; Yang WR; Ye SB; Li R; Ma HH; Zhang RS; Lu ZF; Zhou XJ; Rao Q
    Zhonghua Bing Li Xue Za Zhi; 2017 Jan; 46(1):38-42. PubMed ID: 28072975
    [No Abstract]   [Full Text] [Related]  

  • 5. Molecular Characterization of Metanephric Adenoma, Epithelial Wilms Tumor, and Overlap Lesions: An Integrated Whole-exome and Transcriptome Sequencing Analysis.
    Pan CC; Tseng CE; Kuroda N; Yano M; Yasuda M; Nagashima Y; Yeh YC; Wang YC; Chang YH; Epstein JI
    Appl Immunohistochem Mol Morphol; 2022 Apr; 30(4):257-263. PubMed ID: 35384875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-methylacyl-CoA racemase as a marker in the differential diagnosis of metanephric adenoma.
    Olgac S; Hutchinson B; Tickoo SK; Reuter VE
    Mod Pathol; 2006 Feb; 19(2):218-24. PubMed ID: 16424894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metanephric adenoma, nephrogenic rests, and Wilms' tumor: a histologic and immunophenotypic comparison.
    Muir TE; Cheville JC; Lager DJ
    Am J Surg Pathol; 2001 Oct; 25(10):1290-6. PubMed ID: 11688464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of cadherin17 in metanephric adenoma and its value in differential diagnosis].
    Wang X; Wu N; Yang WR; Shi SS; Ma HH; Wei X; Zhou XJ; Rao Q
    Zhonghua Bing Li Xue Za Zhi; 2016 Jul; 45(7):457-61. PubMed ID: 27430690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cadherin 17 is a sensitive and specific marker for metanephric adenoma.
    Yakirevich E; Magi-Galluzzi C; Grada Z; Lu S; Resnick MB; Mangray S
    Am J Surg Pathol; 2015 Apr; 39(4):479-86. PubMed ID: 25768256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KANK1-NTRK3 fusions define a subset of BRAF mutation negative renal metanephric adenomas.
    Catic A; Kurtovic-Kozaric A; Sophian A; Mazur L; Skenderi F; Hes O; Rohan S; Rakheja D; Kogan J; Pins MR
    BMC Med Genet; 2020 Oct; 21(1):202. PubMed ID: 33046021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Composite tumor of metanephric adenoma and Wilms' tumor of the kidney: A case report and review of the literature.
    Zhu P; Yan F; Yang Z; Meng L; Ao Q
    Oncol Lett; 2013 Apr; 5(4):1311-1314. PubMed ID: 23599785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct clinicopathological features in metanephric adenoma harboring BRAF mutation.
    Caliò A; Eble JN; Hes O; Martignoni G; Harari SE; Williamson SR; Brunelli M; Osunkoya AO; Wang L; Comperat E; Lopez-Beltran A; Wang M; Zhang S; Curless KL; Post KM; Chang HY; Luchini C; Baldrige LA; MacLennan GT; Montironi R; Grignon DJ; Cheng L
    Oncotarget; 2017 Aug; 8(33):54096-54105. PubMed ID: 28903326
    [No Abstract]   [Full Text] [Related]  

  • 13. The spectrum of metanephric adenofibroma and related lesions: clinicopathologic study of 25 cases from the National Wilms Tumor Study Group Pathology Center.
    Arroyo MR; Green DM; Perlman EJ; Beckwith JB; Argani P
    Am J Surg Pathol; 2001 Apr; 25(4):433-44. PubMed ID: 11257617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterisation of metanephric adenomas beyond BRAF: genetic evidence for potential malignant evolution.
    Chan E; Stohr BA; Croom NA; Cho SJ; Garg K; Troxell ML; Higgins JP; Bean GR
    Histopathology; 2020 Jun; 76(7):1084-1090. PubMed ID: 32064677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metanephric adenoma: the utility of immunohistochemical and cytogenetic analyses in differential diagnosis, including solid variant papillary renal cell carcinoma and epithelial-predominant nephroblastoma.
    Kinney SN; Eble JN; Hes O; Williamson SR; Grignon DJ; Wang M; Zhang S; Baldrige LA; Martignoni G; Brunelli M; Wang L; Comperat E; Fan R; Montironi R; MacLennan GT; Cheng L
    Mod Pathol; 2015 Sep; 28(9):1236-48. PubMed ID: 26248896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metanephric adenoma vs. Wilms' tumor: a report of 2 cases with diagnosis by fine needle aspiration and cytologic comparisons.
    Khayyata S; Grignon DJ; Aulicino MR; Al-Abbadi MA
    Acta Cytol; 2007; 51(3):464-7. PubMed ID: 17536557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clear cell sarcoma, cellular mesoblastic nephroma and metanephric adenoma: cytological features and differential diagnosis with Wilms tumour.
    Portugal R; Barroca H
    Cytopathology; 2008 Apr; 19(2):80-5. PubMed ID: 17681013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metanephric Adenoma with cystic changes- An uncommon presentation of a rare tumor in a young adult.
    Shangpliang D; Baishya P; Mishra J; Marbaniang E; Dey B; Wankhar B; Saikia R
    Autops Case Rep; 2020 Jun; 10(3):e2020148. PubMed ID: 33344292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adult Wilms Tumor: Genetic Evidence of Origin of a Subset of Cases From Metanephric Adenoma.
    Argani P; Tickoo SK; Matoso A; Pratilas CA; Mehra R; Tretiakova M; Sibony M; Meeker AK; Lin MT; Reuter VE; Epstein JI; Gagan J; Palsgrove DN
    Am J Surg Pathol; 2022 Jul; 46(7):988-999. PubMed ID: 35184066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRAF mutations in pediatric metanephric tumors.
    Chami R; Yin M; Marrano P; Teerapakpinyo C; Shuangshoti S; Thorner PS
    Hum Pathol; 2015 Aug; 46(8):1153-61. PubMed ID: 26014474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.